HOSPITAL FOR SPECIAL SURGERY
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $34.6M
- Transactions
- 2,366
- Companies
- 40
- Average per transaction
- $14,641
Who reported the payments
| Lima USA, Inc. | $6,266,852 |
| Exactech, Inc. | $6,044,577 |
| Smith+Nephew | $3,906,437 |
| GE HealthCare | $2,615,364 |
| Stryker | $2,013,101 |
| Zimmer Biomet | $1,061,947 |
| Gilead | $1,060,415 |
| Globus Medical | $949,917 |
| Radius Health, Inc. | $943,692 |
| Medical Device Business Services, Inc. | $936,069 |
| Amgen | $815,557 |
| Regeneron | $549,722 |
| UCB SA | $468,164 |
| E.r. Squibb & Sons, L.L.C. | $464,533 |
| Pfizer | $456,047 |
| Synthes GmbH | $437,000 |
| Medtronic | $421,809 |
| Limacorporate S.p.a. | $406,539 |
| Expanding Innovations, Inc. | $279,300 |
| GE Global Research An Unincorporated Business Of GE Company | $250,708 |
| AstraZeneca | $225,742 |
| Novartis | $203,048 |
| Orthofix Medical, Inc. | $188,044 |
| Miach Orthopaedics, Inc. | $177,701 |
| Siemens Medical Solutions USA, Inc. | $168,483 |
| Alphatec Spine, Inc | $160,500 |
| Arthrex | $157,321 |
| Takeda Pharmaceuticals U.S.A., Inc. | $139,659 |
| DJO, LLC | $136,934 |
| Astrazeneca UK Limited | $132,840 |
| Genentech, Inc. | $122,357 |
| Centinel Spine, LLC | $109,353 |
| Biofire Diagnostics, LLC | $102,106 |
| Si-bone, Inc. | $100,366 |
| Orion Corporation | $92,906 |
| Pacira Pharmaceuticals Incorporated | $90,000 |
| Extremity Medical | $84,239 |
| Joint Restoration Foundation, Inc. | $83,610 |
| Ossur Americas, Inc. | $81,250 |
| AbbVie | $80,534 |